Catalyst Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Sell |
|
|||||
|
2025
Q1 | $97.9K | Sell |
|
|||||
|
2024
Q4 | $3.84M | Sell |
|
|||||
|
2024
Q3 | $4.54M | Sell |
|
|||||
|
2024
Q2 | $4.73M | Sell |
|
|||||
|
2024
Q1 | $4.24M | Sell |
|
|||||
|
2023
Q4 | $4.2M | Sell |
|
|||||
|
2023
Q3 | $3.87M | Sell |
|
|||||
|
2023
Q2 | $4.03M | Sell |
|
|||||
|
2023
Q1 | $3.8M | Buy |
|
|||||
|
2022
Q4 | $3.18M | Buy |
|
|||||
|
2022
Q3 | $59K | Buy |
|
|||||
|
2022
Q2 | $57K | Buy |
|
|||||
|
2022
Q1 | $46K | Buy |
|
|||||
|
2021
Q4 | $32K | Sell |
|
|||||
|
2021
Q3 | $28K | Sell |
|
|||||
|
2021
Q2 | $32K | Buy |
|
|||||
|
2021
Q1 | $33K | Sell |
|
|||||
|
2020
Q4 | $43K | Sell |
|
|||||
|
2020
Q3 | $7.85M | Sell |
|
|||||
|
2020
Q2 | $8.91M | Sell |
|
|||||
|
2020
Q1 | $7.97M | Buy |
|